These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29384668)

  • 1. Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts.
    Crestey F; Jensen AA; Soerensen C; Magnus CB; Andreasen JT; Peters GHJ; Kristensen JL
    J Med Chem; 2018 Feb; 61(4):1719-1729. PubMed ID: 29384668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists.
    Crestey F; Jensen AA; Borch M; Andreasen JT; Andersen J; Balle T; Kristensen JL
    J Med Chem; 2013 Dec; 56(23):9673-82. PubMed ID: 24187998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
    Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
    J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New quinoline derivatives as nicotinic receptor modulators.
    Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
    Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues.
    Ondachi PW; Castro AH; Sherman B; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
    ACS Chem Neurosci; 2017 Jan; 8(1):115-127. PubMed ID: 27726337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists.
    Zhang HK; Eaton JB; Fedolak A; Gunosewoyo H; Onajole OK; Brunner D; Lukas RJ; Yu LF; Kozikowski AP
    Eur J Med Chem; 2016 Nov; 124():689-697. PubMed ID: 27639361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
    Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
    J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
    J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists.
    Liu J; Eaton JB; Caldarone B; Lukas RJ; Kozikowski AP
    J Med Chem; 2010 Oct; 53(19):6973-85. PubMed ID: 20822184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine.
    Hauser TA; Hepler CD; Kombo DC; Grinevich VP; Kiser MN; Hooker DN; Zhang J; Mountfort D; Selwood A; Akireddy SR; Letchworth SR; Yohannes D
    Neuropharmacology; 2012 Jun; 62(7):2239-50. PubMed ID: 22306792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
    Boess FG; De Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Riedl B; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; Koenig G
    J Pharmacol Exp Ther; 2007 May; 321(2):716-25. PubMed ID: 17308038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.
    Ondachi PW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
    ACS Chem Neurosci; 2016 Jul; 7(7):1004-12. PubMed ID: 27166021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
    J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An electrophysiological characterization of naturally occurring tobacco alkaloids and their action on human α4β2 and α7 nicotinic acetylcholine receptors.
    Alijevic O; McHugh D; Rufener L; Mazurov A; Hoeng J; Peitsch M
    Phytochemistry; 2020 Feb; 170():112187. PubMed ID: 31865001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
    Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
    Talka R; Salminen O; Tuominen RK
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonicotinic analogues: selective antagonists for α4β2 nicotinic acetylcholine receptors.
    Faundez-Parraguez M; Farias-Rabelo N; Gonzalez-Gutierrez JP; Etcheverry-Berrios A; Alzate-Morales J; Adasme-Carreño F; Varas R; Bermudez I; Iturriaga-Vasquez P
    Bioorg Med Chem; 2013 May; 21(10):2687-94. PubMed ID: 23561269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.